ProMIS Neurosciences, Inc. (PMN)
12.90
-1.08
(-7.69%)
USD |
NASDAQ |
Sep 03, 16:00
13.07
+0.17
(+1.32%)
After-Hours: 20:00
ProMIS Neurosciences Market Cap : 115.68M for Sept. 3, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 03, 2026 | 115.68M |
| September 02, 2026 | 125.32M |
| September 01, 2026 | 119.72M |
| August 31, 2026 | 117.21M |
| August 28, 2026 | 123.62M |
| August 27, 2026 | 125.46M |
| August 26, 2026 | 129.67M |
| August 25, 2026 | 137.74M |
| August 24, 2026 | 132.72M |
| August 21, 2026 | 130.12M |
| August 20, 2026 | 133.71M |
| August 19, 2026 | 131.47M |
| August 18, 2026 | 134.34M |
| August 17, 2026 | 131.47M |
| August 14, 2026 | 133.26M |
| August 13, 2026 | 132.63M |
| August 12, 2026 | 130.03M |
| August 11, 2026 | 134.25M |
| August 10, 2026 | 132.00M |
| August 07, 2026 | 131.91M |
| August 06, 2026 | 119.54M |
| August 05, 2026 | 120.88M |
| August 04, 2026 | 121.69M |
| August 03, 2026 | 126.80M |
| July 31, 2026 | 123.04M |
| Date | Value |
|---|---|
| July 30, 2026 | 133.80M |
| July 29, 2026 | 126.09M |
| July 28, 2026 | 130.21M |
| July 27, 2026 | 105.10M |
| July 24, 2026 | 109.41M |
| July 23, 2026 | 113.08M |
| July 22, 2026 | 125.46M |
| July 21, 2026 | 129.94M |
| July 20, 2026 | 135.19M |
| July 17, 2026 | 136.22M |
| July 16, 2026 | 119.27M |
| July 15, 2026 | 125.59M |
| July 14, 2026 | 122.50M |
| July 13, 2026 | 114.79M |
| July 10, 2026 | 127.79M |
| July 09, 2026 | 127.97M |
| July 08, 2026 | 123.57M |
| July 07, 2026 | 121.51M |
| July 06, 2026 | 122.95M |
| July 02, 2026 | 119.72M |
| July 01, 2026 | 120.62M |
| June 30, 2026 | 118.01M |
| June 29, 2026 | 96.40M |
| June 26, 2026 | 94.43M |
| June 25, 2026 | 91.92M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Edesa Biotech, Inc. | 45.85M |
| Arrowhead Pharmaceuticals, Inc. | 12.21B |
| Oncolytics Biotech, Inc. | 106.75M |
| Sangamo Therapeutics, Inc. | 68.85M |
| Sarepta Therapeutics, Inc. | 2.428B |
Market Cap Related Metrics
| PEG Ratio | -0.0116 |
| Price to Book Value | 2.342 |
| Price | 12.90 |
| Earnings Yield | -104.1% |
| PEGY Ratio | -0.0116 |